David M. Rubenstein Carlyle Group Inc. (CG) insider trading activity

David M. Rubenstein is Director of Carlyle Group Inc.. Currently has a direct ownership of 28 Million shares of CG, which is worth approximately $1.49 Billion. The most recent transaction as insider was on Dec 10, 2025, when has been sold 625,000 shares (Common Stock) at a price of $56.55 per share, resulting in proceeds of $35,343,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28M

4.27% 3M change

4.27% 12M change

Total Value Held $1.49 Billion

David M. Rubenstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2025	SELL Open market or private sale	$35,343,750 $56.55 p/Share	625,000 Reduced 2.18%	27,999,644 Common Stock
Dec 10 2025	SELL Bona fide gift	-	625,000 Reduced 2.14%	28,624,644 Common Stock
Jun 06 2022	SELL Open market or private sale	$77,339,996 $38.67 p/Share	2,000,000 Reduced 6.4%	29,249,644 Common Stock
Nov 09 2021	SELL Open market or private sale	$116,000,000 $58.0 p/Share	2,000,000 Reduced 6.02%	31,249,644 Common Stock
Aug 13 2021	SELL Open market or private sale	$91,827,003 $48.33 p/Share	1,900,000 Reduced 5.41%	33,249,644 Common Stock
Aug 11 2021	SELL Open market or private sale	$97,565,998 $46.46 p/Share	2,100,000 Reduced 5.64%	35,149,644 Common Stock
May 18 2021	SELL Open market or private sale	$83,519,997 $41.76 p/Share	2,000,000 Reduced 5.1%	37,249,644 Common Stock

Mar 11 2021	SELL Open market or private sale	$107,399,998 $35.8 p/Share	3,000,000 Reduced 7.1%	39,249,644 Common Stock
Dec 10 2020	SELL Open market or private sale	$21,787,499 $29.05 p/Share	750,000 Reduced 1.74%	42,249,644 Common Stock
Nov 24 2020	SELL Open market or private sale	$54,599,998 $27.3 p/Share	2,000,000 Reduced 4.44%	42,999,644 Common Stock
Nov 09 2020	SELL Open market or private sale	$54,639,999 $27.32 p/Share	2,000,000 Reduced 4.26%	44,999,644 Common Stock
Jan 01 2020	BUY Conversion of derivative security	-	46,999,644 Added 50.0%	46,999,644 Common Stock

Also insider at

MRNA

Moderna, Inc. Healthcare

Director

DMR